Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Boston-area start-up Manus Bio has raised $19.4 million in its first round of venture funding from investors, including 415 Investments and NXT Ventures. Manus, based on technology developed at MIT, aims to produce ingredients by fermentation that are normally derived from plants. The company is targeting what it calls rare and expensive ingredients used in flavors, fragrances, cosmetics, agriculture, nutrition, and pharmaceuticals. It has disclosed programs to manufacture the stevia sweetener rebaudioside M, the antimalarial artemisinin, and the tick and mite pesticide acaricide.
This article has been sent to the following recipient: